Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Dooren

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vox Sanguinis|January 1, 1993
Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetusM C Dooren, C P Engelfriet
Transfusion Medicine (Oxford, England)|September 1, 1995
Red cell antibodies in pregnancy: there is no 'critical titre'B A van Dijk, M C Dooren, M A Overbeeke
Blood|October 15, 1991
Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor IR W Kuijpers, M C Dooren, A E von dem Borne, et al.
Vox Sanguinis|January 1, 1993
Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newbornM C Dooren, I L van Kamp, H H Kanhai, et al.
Vox Sanguinis|January 1, 1994
No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic diseaseM C Dooren, I L van Kamp, J W Scherpenisse, et al.
Lancet (London, England)|May 2, 1992
Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR)M C Dooren, R W Kuijpers, E C Joekes, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vox Sanguinis|January 1, 1993
Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetusM C Dooren, C P Engelfriet
Transfusion Medicine (Oxford, England)|September 1, 1995
Red cell antibodies in pregnancy: there is no 'critical titre'B A van Dijk, M C Dooren, M A Overbeeke
Blood|October 15, 1991
Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor IR W Kuijpers, M C Dooren, A E von dem Borne, et al.
Vox Sanguinis|January 1, 1993
Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newbornM C Dooren, I L van Kamp, H H Kanhai, et al.
Vox Sanguinis|January 1, 1994
No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic diseaseM C Dooren, I L van Kamp, J W Scherpenisse, et al.
Lancet (London, England)|May 2, 1992
Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR)M C Dooren, R W Kuijpers, E C Joekes, et al.
Pageof 1